Apart from conventional immunosuppressors, novel biologic agents such as interferon-a (IFN-α), tumor necrosis factor-a (TNF-α) inhibitors, different bio-agents targeting interleukins and related receptors were found to show a significant improvement in the visual prognosis of BD patients. This evidence concerns the gene TNF and Behcet disease.